AMA restricts drug rep “shadowing”
Executive Summary
Presence of pharmaceutical sales reps in clinical situations without patient consent is banned by American Medical Association House of Delegates June 17 during annual meeting in Chicago. "The practice of 'shadowing' by pharmaceutical representatives should be prohibited and the AMA should collaborate with industry representatives in promulgating guidelines to that effect," committee report states...